Background {#section1-1073274818799306}
==========

The human papillomavirus (HPV) is one of the most common sexually transmitted infections of the reproductive tract in the world.^[@bibr1-1073274818799306]^ The roles of high-risk HPVs (HR-HPVs) in different cancers, including oropharyngeal, anal, cervical, vaginal, vulvar, and penile, have been established.^[@bibr2-1073274818799306]^ The incidence of HPV-associated cancers has increased over the last 50 years, and the predominance has shifted from a female to a male cancer.^[@bibr2-1073274818799306][@bibr3-1073274818799306]-[@bibr4-1073274818799306]^ Cervical cancer is one of the most preventable human cancers; its prevention is based on early diagnosis and treatment.^[@bibr4-1073274818799306],[@bibr5-1073274818799306]^ The prevalence and mortality of cervical cancer have significantly decreased in developed nations due to widespread applications of Pap smear tests and vaccination. However, developing countries lack well-organized screening programs, which results in greater mortalities in these countries.^[@bibr6-1073274818799306]^

According to the World Health Organization and the estimates of different published studies, there are 3 leading causes of the increased cervical cancer prevalence and mortality in developing countries of the world: (1) a lack of well-organized cervical cancer screening programs, (2) a lack of health-care facilities, and (3) a lack of HPV vaccination among female population in the world particularly China.^[@bibr7-1073274818799306][@bibr8-1073274818799306]-[@bibr9-1073274818799306]^

Knowledge and awareness about cervical cancer, HPV, and the efficacy of the HPV vaccine in the prevention of cervical cancer are very low in the world, especially in China. Some studies have demonstrated that awareness about cervical cancer and HPV is substantially different among different populations in China.^[@bibr10-1073274818799306][@bibr11-1073274818799306]-[@bibr12-1073274818799306]^ Moreover, previously reported studies from various well-developed areas in China with high levels of social and economic disparity make the findings less applicable to all of China.^[@bibr12-1073274818799306]^ Therefore, the current study was designed to assess the following: (1) knowledge in HPV positive versus HPV negative women about cervical cancer, HPV and the HPV vaccine among Chinese women in the Yunnan province, (2) the factors associated with knowledge about HPV, the HPV vaccine, and HPV-associated cancers.

Methodology {#section2-1073274818799306}
===========

Type of Study {#section3-1073274818799306}
-------------

This is a cross-sectional descriptive study. The questionnaires were administered by an interviewer; every women who had an appointment was invited to participate. A standardized questionnaire was designed based on previously published study.^[@bibr13-1073274818799306]^

Ethical Approval {#section4-1073274818799306}
----------------

All the participants voluntarily signed the documented consent prior to their participation, and the security, anonymity, and the privacy of participants were respected rigorously in this study. The ethics committee of the Kunming University of Science and Technology formally reviewed and approved our study.

Study Population {#section5-1073274818799306}
----------------

This survey was conducted by the Faculty of Life Science and Technology of Kunming University of Science and Technology in partnership with the First Peoples' Hospital of Yunnan Province. Women who visited the outpatient department of the First Peoples' Hospital of Yunnan Province were recruited from November 2015 to January 2016.

A copy of the questionnaire was sent to a gynecologist who worked in the outpatient department of the Yunnan First Peoples' Hospital. She agreed to appoint female doctors for the collection of data from the patients. Before beginning the interview, a cover letter that described the aim of the study, conveyed a guarantee of secrecy, and highlighted that the patient's decision to participate would not affect her medical checkup was given to the patient. The overall response rate was 74.9% (487/675).

All women were interviewed by a trained interviewer in their local Chinese dialect in an isolated room using a standardized questionnaire to elicit information about the subjects' demographic and social variables, sexual behavior, medical and reproductive histories, and smoking and drinking habits. After questioner process, a qualified gynecologist did the pelvic examination and sample collection process. One cervical sample was collected with a cyto-brush (Hybribio) for HPV diagnosis.

DNA Extractions and HPV Testing {#section6-1073274818799306}
-------------------------------

The DNA extraction process was completed through the DNA Extraction Kit (Qiagen, Valencia, California) by following the recommendation of manufacturer. Samples that tested positive for β-globin were analyzed by polymerase chain reaction (PCR) amplification of HPV DNA. The HPV-positive samples were confirmed by PCR with universal L1 primer MY09/11 and GP5/6 systems; DNA from HeLa and Caski cell lines was used as positive controls, and mixtures without sample DNA were used as negative controls. The HPV genotypes were determined using an HPV GenoArray Test Kit (Hybribio, Chaozhou, China), according to the manufacturer's instructions. Geno-Array is an L1 consensus primer-based PCR assay that is capable of amplifying 23 HPV genotypes, including 13 HR-HPV genotypes (HPV-16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, and 68), 3 Potential High-Risk (PHR)-HPV genotypes (HPV-53, 66, and 81), and 7 low-risk HPV genotypes (HPV-6, 11, 42, 43, 44, and 61).

Data Analysis {#section7-1073274818799306}
-------------

The data collected from the participants were transferred into a database, and descriptive and inferential statistics were applied using SPSS version 20.0 (SPSS Inc, Chicago, Illinois, for Windows). The participants were divided into HPV-positive and HPV-negative subgroups to examine the relationships of cervical cancer with the HPV-related knowledge, attitudes, behaviors, and intentions of the participants. We applied the χ^2^ test to examine differences between the groups. Awareness and knowledge about HPV, cervical cancer, and the HPV-vaccine are presented as percentages. The associations of various variables with the knowledge and awareness about cervical cancer, HPV, and the HPV vaccine were calculated with a logistic regression model. All statistical tests were 2-sided, and *P* values \<.05 were considered statistically significant.

Results {#section8-1073274818799306}
=======

A total of 487 women were included in this study. Among them, 92 were found to be HPV DNA-positive (18.9%, 92/487), and 395 were HPV-negative. The mean age of the 487 women was 38.3 years (38.3 ± 9.0, confidence interval \[CI\]: 37.4-39.1), and there was no significant difference in age between the HPV-negative (38.3 years \[median = 38\], standard deviation \[SD\] = 9.1, CI: 37.4-39.2) and HPV-positive groups (38.1 years \[median = 38\], SD = 9.4, CI: 36.1-40.0; *P* = .81). The sociodemographic characteristics are presented in [Table 1](#table1-1073274818799306){ref-type="table"}.

###### 

Demographic Characteristics of the Participants.

![](10.1177_1073274818799306-table1)

  Characteristic                   Frequency   Percent
  -------------------------------- ----------- ---------
  Ethnicity                                    
   Han                             406         83.4
   Other                           81          16.6
  Region                                       
   East                            281         57.7
   other region                    98          20.1
   Other province                  108         22.2
  Age                                          
   ≤29                             63          12.9
   30-39                           154         31.6
   40-49                           180         37.0
   ≥50                             90          18.5
  Religious beliefs                            
   Yes                             22          4.5
   No                              465         95.5
  Education                                    
   Illiterate and primary school   84          19.3
   Secondary school                255         52.4
   College and above               138         28.3
  Occupation                                   
   Farmer                          71          14.6
   Staff                           128         26.2
   Self-employed and service       154         31.6
   Other                           134         27.5
  Marital status                               
   Married                         458         94.0
   Single                          29          6.0
  Monthly Income                               
   \<3000                          208         42.7
   3000-5000                       116         23.8
   5100-8000                       85          17.5
   \>5000                          78          16.0
  Smoking                                      
   Yes                             10          2.1
   No                              477         97.9
  Drinking                                     
   Yes                             36          7.4
   No                              451         92.6
  Contraceptive methods                        
   Condom                          193         39.6
   Intrauterine Device (IUD)       120         24.6
   Others                          57          11.7
   None                            117         24.1
  Number of sexual partners                    
   1                               381         78.2
   2                               77          15.8
   ≥3                              29          6.0
  The age of first sex                         
   ≤20                             157         32.2
   21-23                           176         36.1
   ≥24                             154         31.7
  Sexual frequency                             
   ≥1/week                         278         57.1
   \>1/week                        209         42.9
  Childbearing history                         
   0                               75          15.4
   1                               239         49.1
   ≥2                              173         35.5

A total of 78.6% (383/487) women had heard about cervical cancer. Knowledge about cervical cancer prevention through screening was significantly higher among the HPV-negative group (55.9%) than the HPV-positive group (67.4%). Fifty-eight percentage (251/487) of the participants had acquired information about cervical cancer from medical workers. Medical workers acted as a source of knowledge about cervical cancer for significantly more of the HPV-positive women (66.7%) than the HPV-negative women (58.9%). Similarly, the levels of knowledge about HPV and its role in cervical cancer were higher among the HPV-negative women (HPV: 53.2, role in cervical cancer \[CC\] 38.7%) than the HPV-positive women (HPV: 42.4, role in CC 43.5%). The level of knowledge about the role of HPV in other related cancers was significantly higher among the HPV-positive women (20.6%) than the HPV-negative women (9.1%; [Table 2](#table2-1073274818799306){ref-type="table"}).

###### 

Levels of Knowledge About HPV and Its Vaccination Among the HPV-Positive and HPV-Negative Groups.^a^

![](10.1177_1073274818799306-table2)

  Variable                                                                                  Total        HPV Positive (n = 92)   HPV Negative (n = 395)   *P* Value
  ----------------------------------------------------------------------------------------- ------------ ----------------------- ------------------------ -----------
  Do you know about cervical cancer?                                                        416 (85.4)   75 (81.5)               341 (86.3)               .239
  Do you know that cancer can be prevented with cervical cancer screening tests?            383 (78.6)   68 (73.9)               315 (79.7)               .26
  Have you undergone a cervical cancer screening?                                           283 (58.1)   62 (67.4)               221 (55.9)               .045
  Is your main source of information about cervical cancer a medical worker?                251 (51.5)   50 (66.7)               201 (58.9)               .005
  Do you know about HPV?                                                                    249 (51.1)   39 (42.4)               210 (53.2)               .063
  Do you know that HPV can transmit through sex?                                            150 (30.8)   30 (32.6)               120 (30.4)               .257
  Do you know that HPV infection can lead to cervical cancer?                               193 (39.6)   40 (43.5)               153 (38.7)               .402
  Do you know that HPV can cause other related cancers?                                     55 (11.3)    19 (20.6)               36 (9.1)                 .002
  Is your main source of information about HPV a medical worker?                            183 (37.6)   25 (64.1)               158 (75.2)               .300
  Do you know about the HPV vaccine?                                                        75 (15.4)    23 (25.0)               53 (13.8)                .006
  Do you know that the HPV vaccine can prevent cervical cancer and other related cancers?   55 (11.3)    19 (20.6)               36 (9.1)                 .002
  Is the HPV vaccine only for women?                                                        487          92 (100)                395 (100)                \-
  Are you willing to be vaccinated if the vaccine is free of charge?                        444 (91.2)   86 (93.5)               358 (90.6)               .687

Abbrevaition: HPV, human papillomavirus.

^a^The variables indicate significant differences (*P* = .05); n = number of participants.

The overall levels of awareness and knowledge about the HPV vaccine were very low among both groups. The levels of knowledge about the HPV vaccine and its role in cervical cancer prevention were significantly higher among the HPV-positive (25.0%, role in CC prevention: 20.6%) women than the HPV-negative women (13.8%, role in CC prevention: 9.1%). The level of willingness to receive the HPV vaccine was high in both groups. Surprisingly, none of the women knew that HPV vaccine could also be used for men (0%, 0/487).

We also collected data regarding the participants' high or low levels of knowledge and awareness about the risk factors for cervical cancer ([Table 3](#table3-1073274818799306){ref-type="table"}), HPV ([Table 4](#table4-1073274818799306){ref-type="table"}) and the HPV vaccine ([Table 5](#table5-1073274818799306){ref-type="table"}). The levels of knowledge and awareness about cervical cancer and HPV were significantly higher among populations with higher education levels, higher income, and higher job status (Tables 3 and4). Furthermore, migrant women (P = .004), women of other ethnicities (*P* = .028), older women, and married women had significantly higher levels of knowledge about cervical cancer and HPV ([Tables 3](#table3-1073274818799306){ref-type="table"} and [4](#table4-1073274818799306){ref-type="table"}). The levels of knowledge and awareness about the HPV vaccine were low among all groups and were significantly lower among the illiterate (*P* = .001) and agricultural workers (*P* = .004; [Table 5](#table5-1073274818799306){ref-type="table"}).

###### 

Logistic Regression Analysis of the Levels of Knowledge About Cervical Cancer.

![](10.1177_1073274818799306-table3)

  Characteristic                   Total   Knowledge     OR (95%CI)          *P* Value
  -------------------------------- ------- ------------- ------------------- -----------
  Residence                                                                  .040
   East                            281     250 (89.0%)   1                   
   Another region                  98      75 (76.5%)    2.56 (1.17-5.60)    
   Other province                  108     92 (85.2%)    1.06 (0.48-2.32)    
  Ethnicity                                                                  .028
   Han                             406     352 (86.7%)   1                   
   Other                           81      65 (80.2%)    2.59 (1.11-6.05)    
  Age                                                                        .074
   ≤29                             63      46 (73.0%)    1                   
   30-39                           154     128 (83.1%)   0.49 (0.17-1.34)    
   40-49                           180     162 (90%)     0.94 (0.32-2.76)    
   ≥50                             90      81 (90%)      1.72 (0.51-5.81)    
  Occupation                                                                 .374
   Farmer                          71      48 (67.6%)    1                   
   Staff                           128     116 (90.6%)   1.06 (0.37-3.06)    
   Self-employed                   154     138 (89.6%)   0.64 (0.24 -1.66)   
   Other                           134     115 (86.8%)   0.53 (0.22 -1.25)   
  Education                                                                  .480
   Illiterate and primary          84      63 (75%)      1                   
   Secondary school                255     216 (84.7%)   0.64 (0.24-1.66)    
   College and above               138     117 (84.8%)   0.00 (0.00-)        
  Monthly income                                                             .620
   \<3000                          208     180 (86.5%)   1                   
   3000-5000                       116     98 (84.5%)    1.36 (0.61-3.06)    
   5100-8000                       85      70 (82.4%)    1.63 (0.69-3.85)    
   \>8000                          78      69 (88.5%)    0.53 (0.22 -1.25)   
  Religious belief                                                           .606
   Yes                             22      20 (90.9%)    1                   
   No                              465     397 (85.4%)   0.64 (0.12-3.42)    
  Marital status                                                             .924
   Married                         458     390 (85.2%)   1                   
   Single                          29      22 (75.9%)    0.93 (0.19-4.44)    
  Childbearing history                                                       .262
   0                               75      73 (97.3%)    1                   
   1                               239     216 (90.4%)   0.94 (0.40-2.20)    
   \>2                             173     127 (73.4%)   1.10 (0.36-3.42)    
  Age at first sexual experience                                             .007
   ≤20                             157     125 (79.6%)   1                   
   21-23                           176     142 (80.7%)   1.05 (0.53-2.08)    
   ≥24                             154     149 (96.8%)   0.18 (0.06-0.57)    
  Number of sexual partners                                                  .325
   1                               381     323 (84.8%)   1                   
   2                               77      66 (85.7%)    2.03 (0.72-5.75)    
   ≥3                              29      27 (93.1%)    0.73 (0.11-5.00)    
  Sexual frequency                                                           .034
   ≥1/week                         278     245 (88.1%)   1                   
   \<1/week                        209     171 (81.8%)   1.98 (1.05-3.73)    
  Contraceptive method                                                       .131
   Condom                          193     184 (95.3%)   1                   
   IUD                             120     100 (83.3%)   2.53 (0.96-6.70)    
   Other                           57      42 (73.7%)    2.10 (0.72-5.75)    
   None                            117     90 (77.0%)    3.10 (1.17-8.11)    
  Smoking                                                                    .893
   Yes                             10      8 (80.0%)     1                   
   No                              477     408 (85.5%)   0.85 (0.08-8.94)    
  Drinking                                                                   .662
   Yes                             36      31 (86.1%)    1                   
   No                              451     385 (85.4%)   0.74 (0.19-2.89)    

Abbreviations: CI confidence interval; IUD, intrauterine device; OR, odds ratio.

###### 

Logistic Regression Analysis of the Levels of Knowledge about HPV.

![](10.1177_1073274818799306-table4)

  Characteristic                   Total   Knowledge     OR (95%CI)          *P* Value
  -------------------------------- ------- ------------- ------------------- -----------
  Residence                                                                  .696
   East                            281     151 (53.7%)   1                   
   Other region                    98      50 (51.0%)    0.79 (0.45-1.38)    
   Other province                  108     48 (44.4%)    0.90 (0.53 -1.55)   
  Ethnicity                                                                  .151
   Han                             406     209 (51.5%)   1                   
   Other                           81      40 (49.4%)    1.55 (0.85-2.82)    
  Age                                                                        .416
   ≤29                             63      53 (84.1%)    1                   
   30-39                           154     91 (59.1%)    1.75 (0.90-3.22)    
   40-49                           180     79 (43.9%)    1.41 (0.70-2.83)    
   ≥50                             90      26 (28.9%)    1.65 (0.67-3.91)    
  Occupation                                                                 .278
   Farmer                          71      20 (28.2%)    1                   
   Staff                           128     86 (67.2%)    0.57 (0.25-1.27)    
   Self-employed and service       154     89 (57.8%)    0.63 (0.29-1.33)    
   Other                           134     54 (40.3%)    0.94 (0.46-1.93)    
  Education                                                                  .002
   Illiterate and primary          84      49 (58.3%)    1                   
   Secondary school                255     137 (53.7%)   0.67 (0.36-1.23)    
   College and above               138     63 (45.7%)    0.25 (0.11-0.57)    
  Monthly income                                                             .461
   \<3000                          208     116 (55.8%)   1                   
   3000-5000                       116     60 (51.7%)    1.02 (0.60-1.73)    
   5100-8000                       85      39 (45.9%)    1.26 (0.70-2.23)    
   \>8000                          78      34 (43.6%)    1.58 (0.86-2.91)    
  Religious belief                                                           .585
   Yes                             22      12 (54.5%)    1                   
   No                              465     237 (51.0%)   1.35 (0.47-3.90)    
  Marital status                                                             .327
   Married                         458     242 (52.8%)   1                   
   Single                          29      7 (24.1%)     0.63 (0.25-1.60)    
  Childbearing history                                                       .002
   0                               75      40 (53.3%)    1                   
   1                               239     153 (64.0%)   0.33 (0.16-0.67)    
   ≥2                              173     56 (32.4%)    0.58 (0.25-1.33)    
  Age at first sexual experience                                             .082
   ≤20                             157     61 (38.9%)    1                   
   21-23                           176     84 (47.7%)    0.76 (0.45-1.28)    
   ≥24                             154     104 (67.5%)   0.51 (0.28-0.92)    
  Number of sexual partners                                                  .285
   1                               381     172 (45.1%)   1                   
   2                               77      59 (76.6%)    0.75 (0.16-0.76)    
   ≥3                              29      17 (58.6%)    0.49 (0.20=-1.25)   
  Sexual frequency                                                           .454
   ≥1/week                         278     147 (52.9%)   1                   
   \<1/week                        209     102 (48.8%)   1.18 (0.76-1.83)    
  Contraceptive methods                                                      .019
   Condom                          193     129 (66.8%)   1                   
   IUD                             120     58 (48.3%)    1.77 (1.01-3.08)    
   Other                           57      18 (31.6%)    1.90 (0.91-3.99)    
   None                            117     44 (37.6%)    2.43 (1.36-4.35)    
  Smoking                                                                    .543
   Yes                             10      4 (40.0%)     1                   
   No                              477     245 (51.4%)   0.60 (0.12-3.10)    
  Drinking                                                                   .895
   Yes                             36      18 (50.0%)    1                   
   No                              451     231 (51.2%)   0.90 (0.37-2.17)    

Abbreviations: CI, confidence interval; IUD, intrauterine device; OR, odds ratio.

###### 

Logistic Regression Analysis of the Levels of Knowledge About the HPV Vaccine.

![](10.1177_1073274818799306-table5)

  Characteristic               Total   Knowledge     OR (95%CI)          *P* Value
  ---------------------------- ------- ------------- ------------------- -----------
  Residence                                                              .145
   East                        281     41 (14.6%)    1                   
   Other region                98      8 (8.2%)      1.87 (0.76-4.60)    
   Other province              108     15 (13.9%)    0.66 (0.31-1.41)    
  Ethnicity                                                              .351
   Han                         406     43 (10.6%)    1                   
   Other                       81      21 (26.0%)    0.69 (0.32-1.50)    
   Age                                                                   .662
   ≤29                         63      12 (19.0%)    1                   
   30-39                       154     15 (9.7%)     0.93 (0.40-2.12)    
   40-49                       180     19 (10.6%)    0.88 (0.34-2.23)    
   ≥50                         90      18 (20.0%)    2.13 (0.45-9.97)    
  Occupation                                                             .044
   Farmer                      71      7 (9.60%      1                   
   Staff                       128     20 (15.6%)    3.98 (1.12-14.01)   
   Self-employed and service   154     19 (12.3%)    4.60 (1.37-15.50)   
   Other                       134     17 (12.7%)    1.77 (0.58-5.40)    
  Education                                                              .001
   Illiterate and primary      84      12 (14.3%)    1                   
   Secondary school            255     19 (7.5%)     0.21 (0.05-0.80)    
   College and above           138     33 (23.9%)    0.06 (0.01-0.27)    
  Monthly income                                                         .170
   \<3000                      208     23 (11.6%)    1                   
   3000-5000                   116     6 (5.2%)      2.23 (0.93-5.50)    
   5100-8000                   85      17 (20.0%)    1.02 (0.46-2.30)    
   \>8000                      78      18 (23.1%)    0.73 (0.33-1.64)    
  Religious belief                                                       .507
   Yes                         22      2 (9.1%)      1                   
   No                          465     62 (133.3%)   1.75 (0.34-9.09)    
  Marital status                                                         .358
   Married                     458     57 (12.4%)    1                   
   Single                      29      7 (24.1%)     1.69 (0.55-5.16)    
  Childbearing history                                                   .929
   0                           75      16 (21.3%)    1                   
   1                           239     35 (14.6%)    0.94 (0.40-2.20)    
   ≥2                          173     13 (7.5%)     1.10 (0.36-3.42)    
  Sexual partners                                                        .027
   1                           381     40 (10.5%)    1                   
   2                           77      20 (26.0%)    0.35 (0.16-0.76)    
   ≥3                          29      4 (13.8%)     0.70 (0.19-2.58)    
  Sexual frequency                                                       .662
   ≥1/week                     278     38 (13.7%)    1                   
   \<1/week                    209     26 (12.4%)    1.15 (0.61-2.15)    
  Contraceptive methods                                                  .716
   Condom                      193     35 (18.1%)    1                   
   IUD                         120     15 (12.5%)    0.97 (0.45-2.10)    
   Other                       57      6 (10.5%)     0.68 (0.22-2.08)    
   None                        117     8 (6.8%)      1.43 (0.56-3.62)    
  Smoking                                                                .666
   Yes                         10      1 (10%)       1                   
   No                          477     63 (13.2%)    0.59 (0.05-6.66)    
  Drinking                                                               .766
   Yes                         36      6 (16.7%)     1                   
   No                          451     58 (12.9%)    1.20 (0.37-3.80)    

Abbreviations: CI, confidence interval; IUD, intrauterine device; OR, odds ratio.

Discussion {#section9-1073274818799306}
==========

Vaccination against HPV is a possible long-term solution for eradicating cervical cancer in developing countries, particularly in China, where a prophylactic HPV vaccine has already been approved. Yunnan province has a unique geographical location, highly complex topography, and large variations in elevation. Yunnan Province is a land of 26 Chinese ethnic groups. The health-care facilities in this region are inadequate, and there is a lack of well-organized cancer registries and gynaecological screening and HPV testing programs. In 2014, our group took initiative and reported HPV prevalence and its genotype distribution among various ethnic groups in Yunnan province.^[@bibr14-1073274818799306][@bibr15-1073274818799306]-[@bibr16-1073274818799306]^ Recently, cervical cancer screening test is available in almost all public hospitals. The current study is the first to assess the levels of awareness and knowledge about cervical cancer, HPV, and the HPV vaccine among women in the Yunnan province, which is a developing area located in the southwest of China. Considering the substantial differences in the levels of knowledge and awareness about HPV-related cancer, HPV, and HPV vaccine acceptance among women across the world, and especially in China, this survey will be helpful for designing strategies for cervical cancer control via HPV screening and vaccination in Yunnan province, China.

The findings indicate a good level of knowledge and awareness about cervical cancer (85.4%); however, the level of knowledge and awareness about HPV was moderate (51.1%), and the level of knowledge and awareness about the HPV vaccine was very low (15.4%). Numerous previously reported surveys have demonstrated that 50% to 85% of women know about cervical cancer in Asia,^[@bibr17-1073274818799306],[@bibr18-1073274818799306]^ which is in accordance with the observations of our study. Human papillomavirus awareness was higher in Denmark (75.8%) and Sweden (74.8%) compared with Norway (62.4%) and Senegal (63%),^[@bibr19-1073274818799306],[@bibr20-1073274818799306]^ while studies from Yunnan, China (52.6%), Xinjiang, China (0.14%, 10 out of 7100), and Brazil (37%) have reported low levels of knowledge and awareness about HPV that are consistent with the findings of this study.^[@bibr13-1073274818799306],[@bibr21-1073274818799306],[@bibr22-1073274818799306]^ However, the levels of knowledge and awareness about HPV observed in the present study are higher than those in previously reported studies^[@bibr13-1073274818799306],[@bibr23-1073274818799306]^ but are still low. A low level of knowledge about HPV is recognized as a major hurdle for the implementation HPV vaccination programs. Therefore, it is very important that persistent public education efforts be initiated to communicate the information to the population through printed, electronic and social media, and debates with medical doctors and workers to raise awareness about HPV infection and the HPV vaccine.

Yunnan province is located at the threshold of the Himalayas in the south of the People's Republic of China and has a unique geographic location, a highly complex topography, and large variations in elevation. Different regions of Yunnan province have distinct topographical features. Northwestern Yunnan is a sparsely populated area with large mountains, a dry landscape, and cold weather. The southeast region is highly populated, the land is flat, and the weather is hot. We determined the levels of knowledge and awareness about HPV-related cancer, HPV, and the HPV vaccine among HPV-positive and -negative women. We found that knowledge about cervical cancer was higher among HPV-negative than HPV-positive women. However, knowledge about HPV and its vaccine was substantially higher among the HPV-positive than the HPV-negative women. It is well-established that the levels of knowledge and awareness about HPV and its vaccine are very heterogeneous among the general population and specific target groups.^[@bibr24-1073274818799306][@bibr25-1073274818799306]-[@bibr26-1073274818799306]^ Some studies have revealed very low levels of awareness,^[@bibr27-1073274818799306],[@bibr28-1073274818799306]^ eg, the level of knowledge and awareness about HPV and its vaccine among Danish women is 10%,^[@bibr29-1073274818799306]^ which is very low compared with the observations of the present study. This difference might be due to the massive HPV and HPV vaccination awareness campaign organized by the Ministry of Health and implemented through electronic and print media during cervical cancer screenings.

In the present study, the level of knowledge about the HPV vaccine was very low (15.1%), and a similar level has been reported in Brazil.^[@bibr22-1073274818799306]^ We suggest the prioritization of the initiation of a high-level public education campaign regarding the HPV vaccine that will explicitly address knowledge deficits among general populations. Most of the participants stated that they would be vaccinated if the vaccine was available free of cost. Many studies have reported favorable attitudes toward vaccination in China^[@bibr13-1073274818799306],[@bibr21-1073274818799306],[@bibr23-1073274818799306]^ and other countries.^[@bibr17-1073274818799306],[@bibr22-1073274818799306]^ Yunnan is an underdeveloped province of China, and the poverty level is slightly higher than that of the rest of China; thus, many people in this province do not have enough money to pay for the HPV vaccine. Based on these observations, we suggest that the HPV vaccine must be introduced in Yunnan province under a government-subsidized program rather than by the private sector. Another main barrier to vaccination acceptance is concern about side effects. A lack of knowledge about HPV may make it difficult for women to make appropriate decisions. Therefore, clear and sustained educational programs may be needed in both rural and urban areas before the initiation of an HPV vaccination campaign.

The limitations of this study include the fact that the sample was not representative of the general Yunnan population because recruitment was limited to one region of the province. Further extended quantitative and qualitative research involving other areas of the country will provide more relevant information on this issue.

Conclusion {#section10-1073274818799306}
==========

In this study, we found high acceptability of the HPV vaccine in Chinese women and high awareness about cervical cancer. However, very low levels of knowledge about HPVs and their role in cancer development among the recruited women is alarming. Therefore, it is very important to initiate educational programs to raise awareness and knowledge about cervical cancer, HPV, and the HPV vaccine in this region.
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